Given the past 8 months... the company strategy under Sonand moving forward isn't going to be over-promise and under deliver... that's the way I see it.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025